The embodiments herein relate to the combination of herbal and probiotic (optionally with prebiotic) treatment for chronic liver diseases to be novel and more effective. Embodiments herein relate to a composition comprising a probiotic and a medicinal herb (and optionally a prebiotic), wherein the composition is effective in treating a liver disease such as inflammation of liver in a novel approach to disease management. The combination of a prebiotic, a probiotic and a medicinal herb constitutes a symbiotic formulation. Clinical and animal data exists to show efficacy of these combinations. The ingredients, as well as the categories, in the combination are novel. Using a combination of twelve herbs and three probiotics, a highly efficacious and novel supplement is disclosed herein. Embodiments of the compositions herein could further include homeopathic drugs and an active pharmaceutical ingredient such as an allopathic drug.

The embodiments herein relate to the combination of herbal and probiotic (optionally with prebiotic) treatment for chronic liver diseases to be novel and more effective. Embodiments herein relate to a composition comprising a probiotic and a medicinal herb (and optionally a prebiotic), wherein the composition is effective in treating a liver disease such as inflammation of liver in a novel approach to disease management. The combination of a prebiotic, a probiotic and a medicinal herb constitutes a symbiotic formulation. Clinical and animal data exists to show efficacy of these combinations. The ingredients, as well as the categories, in the combination are novel. Using a combination of twelve herbs and three probiotics, a highly efficacious and novel supplement is disclosed herein. Embodiments of the compositions herein could further include homeopathic drugs and an active pharmaceutical ingredient such as an allopathic drug.

The embodiments herein relate to the combination of herbal and probiotic (optionally with prebiotic) treatment for chronic liver diseases to be novel and more effective. Embodiments herein relate to a composition comprising a probiotic and a medicinal herb (and optionally a prebiotic), wherein the composition is effective in treating a liver disease such as inflammation of liver in a novel approach to disease management. The combination of a prebiotic, a probiotic and a medicinal herb constitutes a symbiotic formulation. Clinical and animal data exists to show efficacy of these combinations. The ingredients, as well as the categories, in the combination are novel. Using a combination of twelve herbs and three probiotics, a highly efficacious and novel supplement is disclosed herein. Embodiments of the compositions herein could further include homeopathic drugs and an active pharmaceutical ingredient such as an allopathic drug.

This invention relates to a use of producing a medicinal composition for preventing or treating a disease, disorder or condition induced by retina ischemia, wherein the medicinal composition comprising 4.5 units by weight of Radix Angelicae Sinensis (Dang Gui), 4.5 units by weight of Radix Rehmanniae glutinosae (Di Huang), 3 units by weight of Radix Paeoniae Rubra (Chi Shao), from 2.25 to 2.3 units by weight of Rhizoma Ligustici Chuanxiong (Chuan Xiong), 6 units by weight of Semen Pruni Persicae (Táo Rén), 4.5 units by weight of Flos Carthami Tinctorii (Hong Hua), 1.5 units by weight of Radix Glycyrrhizae Uralensis (Gan Cao), 3 units by weight of Fructus Aurantii (Zhi Qiao), 1.5 units by weight of Radix Bupleuri Chinense (Chai Hu), 4.5 units by weight of Radix Achyranthis Bidentatae (Niu Xi), and from 2.25 to 2.3 units by weight of Radix Platycodi Grandiflori (Jie Geng).

This invention relates to a use of producing a medicinal composition for preventing or treating a disease, disorder or condition induced by retina ischemia, wherein the medicinal composition comprising 4.5 units by weight of Radix Angelicae Sinensis (Dang Gui), 4.5 units by weight of Radix Rehmanniae glutinosae (Di Huang), 3 units by weight of Radix Paeoniae Rubra (Chi Shao), from 2.25 to 2.3 units by weight of Rhizoma Ligustici Chuanxiong (Chuan Xiong), 6 units by weight of Semen Pruni Persicae (Táo Rén), 4.5 units by weight of Flos Carthami Tinctorii (Hong Hua), 1.5 units by weight of Radix Glycyrrhizae Uralensis (Gan Cao), 3 units by weight of Fructus Aurantii (Zhi Qiao), 1.5 units by weight of Radix Bupleuri Chinense (Chai Hu), 4.5 units by weight of Radix Achyranthis Bidentatae (Niu Xi), and from 2.25 to 2.3 units by weight of Radix Platycodi Grandiflori (Jie Geng).

This invention relates to a use of producing a medicinal composition for preventing or treating a disease, disorder or condition induced by retina ischemia, wherein the medicinal composition comprising 4.5 units by weight of Radix Angelicae Sinensis (Dang Gui), 4.5 units by weight of Radix Rehmanniae glutinosae (Di Huang), 3 units by weight of Radix Paeoniae Rubra (Chi Shao), from 2.25 to 2.3 units by weight of Rhizoma Ligustici Chuanxiong (Chuan Xiong), 6 units by weight of Semen Pruni Persicae (Táo Rén), 4.5 units by weight of Flos Carthami Tinctorii (Hong Hua), 1.5 units by weight of Radix Glycyrrhizae Uralensis (Gan Cao), 3 units by weight of Fructus Aurantii (Zhi Qiao), 1.5 units by weight of Radix Bupleuri Chinense (Chai Hu), 4.5 units by weight of Radix Achyranthis Bidentatae (Niu Xi), and from 2.25 to 2.3 units by weight of Radix Platycodi Grandiflori (Jie Geng).

A pharmaceutical composition for preventing and treating cancer of reproductive system and preparation method therefor. The pharmaceutical composition is prepared using one or more of the following as raw material: pinellia tuber, bighead atractylodes rhizome, gastralia tuber, liquorice root, Indian bread, white peony root, fresh ginger.

A pharmaceutical composition for preventing and treating cancer of reproductive system and preparation method therefor. The pharmaceutical composition is prepared using one or more of the following as raw material: pinellia tuber, bighead atractylodes rhizome, gastralia tuber, liquorice root, Indian bread, white peony root, fresh ginger.

The present invention relates to a pharmaceutical composition for treating and preventing degenerative neurological disorders, containing, as an active ingredient, a mixture extract of two or more types selected from the group consisting of Moutan Root Bark, Angelica Dahurica Root, and Bupleurum Root, or a fraction thereof. Specifically, the extract of the mixture of the present invention exhibits a recovery effect on mitochondrial function damage, a relieving effect on endoplasmic reticulum stress and also exhibits simultaneously an inhibitory effect on inflammatory response, which are remarkably improved compared with those exhibited in an in vitro single extract, and the extract of the mixture significantly exhibits an improvement effect on motor coordination and a protective effect on dopaminergic neurons in a Parkinson's disease animal model, and thus the extract of the mixture of the present invention or a fraction thereof can be useful as an active ingredient of a pharmaceutical composition for treating and preventing degenerative neurological disorders.

The present invention relates to a pharmaceutical composition for treating and preventing degenerative neurological disorders, containing, as an active ingredient, a mixture extract of two or more types selected from the group consisting of Moutan Root Bark, Angelica Dahurica Root, and Bupleurum Root, or a fraction thereof. Specifically, the extract of the mixture of the present invention exhibits a recovery effect on mitochondrial function damage, a relieving effect on endoplasmic reticulum stress and also exhibits simultaneously an inhibitory effect on inflammatory response, which are remarkably improved compared with those exhibited in an in vitro single extract, and the extract of the mixture significantly exhibits an improvement effect on motor coordination and a protective effect on dopaminergic neurons in a Parkinson's disease animal model, and thus the extract of the mixture of the present invention or a fraction thereof can be useful as an active ingredient of a pharmaceutical composition for treating and preventing degenerative neurological disorders.